HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 95 filers reported holding HARROW HEALTH INC in Q1 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $193,793 | -95.3% | 13,486 | -93.8% | 0.00% | -100.0% |
| Q2 2023 | $4,119,837 | +39.7% | 216,378 | +55.2% | 0.00% | 0.0% |
| Q1 2023 | $2,950,085 | +43.4% | 139,418 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $2,057,810 | +22.3% | 139,418 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,683,000 | +65.8% | 139,418 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,015,000 | +6.7% | 139,418 | 0.0% | 0.00% | – |
| Q1 2022 | $951,000 | -45.2% | 139,418 | -30.5% | 0.00% | -100.0% |
| Q4 2021 | $1,734,000 | -4.9% | 200,693 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,824,000 | -18.0% | 200,693 | -16.2% | 0.00% | 0.0% |
| Q2 2021 | $2,225,000 | +504.6% | 239,463 | +339.4% | 0.00% | – |
| Q1 2021 | $368,000 | +214.5% | 54,492 | +219.0% | 0.00% | – |
| Q4 2020 | $117,000 | +64.8% | 17,084 | +35.8% | 0.00% | – |
| Q3 2020 | $71,000 | +18.3% | 12,583 | +9.4% | 0.00% | – |
| Q2 2020 | $60,000 | – | 11,503 | +164228.6% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 7 | -97.7% | 0.00% | – |
| Q1 2019 | $1,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,795,000 | $54,534,150 | 17.74% |
| Private Capital Management, LLC | 1,416,900 | $20,360,853 | 2.41% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 91,779 | $1,318,864 | 1.86% |
| Birchview Capital, LP | 150,000 | $2,155,500 | 1.84% |
| Diametric Capital, LP | 286,127 | $4,111,644 | 1.72% |
| Ophir Asset Management Pty Ltd | 492,179 | $7,072,612 | 1.67% |
| BRAIDWELL LP | 1,808,684 | $25,990,789 | 0.82% |
| Westside Investment Management, Inc. | 159,019 | $2,285,117 | 0.66% |
| INVICTUS PRIVATE WEALTH, LLC | 400,066 | $5,748,948 | 0.63% |
| Portolan Capital Management | 385,964 | $5,546,303 | 0.52% |